Market Overview

The Global Acne Therapeutics Market was valued at USD 7,581.0 million in 2023 and is expected to reach USD 11,459.1 million by 2031 while growing at a CAGR of 5.3% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global acne therapeutics market growth. The objective of acne treatment is to prevent the formation of new pimples and heal the existing ones on your skin. Various treatment methods are available, and the choice of treatment depends on factors such as your age, the type of acne you have, and its severity.

Innovations in pharmaceuticals and skincare, such as the development of new drugs and the enhancement of existing treatments, along with an increasing incidence of acne and heightened awareness and social pressures, drive market growth. However, the growth is hindered by the side effects of acne medications and the high cost of prescription treatments.

Furthermore, the global acne therapeutics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Treatment Analysis

The Global Acne Therapeutics Market is segmented among Therapeutics, Retinoid, Antibiotics, Hormonal Agents, Combination Medications, Anti-inflammatory, and Other Agents, based on Treatment. In 2023, Therapeutics accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Route of Administration analysis

The Global Acne Therapeutics Market is segmented among Oral, Topical, and Others, based on Route of Administration. In 2023, Oral accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Acne Therapeutics Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Allergan, Ranbaxy, Bayer Ag, Johnson & Johnson, Nestlé SA (Galderma), Glaxosmithkline Plc, Teva Pharmaceuticals, Cipher Pharmaceuticals, Valeant Pharmaceuticals International Inc., F. Hoffmann-la Roche Ltd.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Acne Therapeutics Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Acne Therapeutics Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Acne Therapeutics Market Segmentation, By Treatment

• Global Acne Therapeutics Market Share Analysis, By Treatment

• Global Acne Therapeutics Market Growth Analysis, By Treatment

• Global Acne Therapeutics Market Trends, By Treatment

o Therapeutics

o Retinoid

o Antibiotics

o Hormonal Agents

o Combination Medications

o Anti-inflammatory

o Other Agents

6. Global Acne Therapeutics Market Segmentation, By Route of Administration

• Global Acne Therapeutics Market Share Analysis, By Route of Administration

• Global Acne Therapeutics Market Growth Analysis, By Route of Administration

• Global Acne Therapeutics Market Trends, By Route of Administration

o Oral

o Topical

o Others

7. Global Acne Therapeutics Market Segmentation, By Region

• Global Acne Therapeutics Market Share Analysis, By Region

• Global Acne Therapeutics Market Growth Analysis, By Region

• Global Acne Therapeutics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Allergan*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Ranbaxy

• Bayer Ag

• Johnson & Johnson

• Nestlé SA (Galderma)

• Glaxosmithkline Plc

• Teva Pharmaceuticals

• Cipher Pharmaceuticals

• Valeant Pharmaceuticals International Inc.

• F. Hoffmann-la Roche Ltd.

*Similar analysis will be provided for each company listed above.